Monday, January 18, 2010

Global Antibiotic Resistance Scenario-By Dr. A.J. Tamhankar

Experimental Antibiotics Should Be Given Orphan Drug Status
Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA for MRSA infection.
Resistance to Antibiotics Can Be Drawback for Bacteria
KaloBios Partners with Sanofi Pasteur on Novel Prevention and Treatment for Pseudomonas aeruginosa -(KaloBios' Humaneered™ Antibody Fragment KB001 Blocks Pseudomonas Virulence)
From CDC
Seagulls and Beaches acting as Reservoirs for Multidrug-Resistant Escherichia coli in Portugal sharing hospital room raises infection risk compared to being hospitalised in a single room.

No comments:

Read The ``TRUE LIFE STORY``of a family infected with MRSA